LAXMIDENTL203.30

Laxmi Dental Limited

· Pharma & Health
₹ CrorePeersFABTECHTARSONSFISCHERGKBMcap ₹1,117 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth+16.2
EBITDA Growth+3.6
EBIT Growth+2.5
Net Income Growth-9.2
EPS Growth-8.7
Total Assets Growth+3.3
Total Equity Growth+17.0
Cash from Operations Growth-111.4
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.